首页> 外文会议>International Congress on Electrocardiology >ELECTROPHARMACOLOGIC EVALUATION OF QUINIDINE IN THE BRUGADA SYNDROME
【24h】

ELECTROPHARMACOLOGIC EVALUATION OF QUINIDINE IN THE BRUGADA SYNDROME

机译:Brugada综合征奎尼丁的电解机学评估

获取原文
获取外文期刊封面目录资料

摘要

(Background)The Bmgada syndrome is known to have a high incidence of sudden cardiac death. The effective treatment is ICD and there is no reliable treatment with drugs. (Purpose)To investigate the effect in preventing ventricular fibrillation (VF) inducibility by programmed electrical stimulation (PES) in symptomatic or asymptomatic patients with the Brugada syndrome after oral administration of quinidine. (Methods)PES was performed in 9 patients(all men,mean age 53.9+-13.0 years) who showed characterstic Brugada type ECG.VF was inducible in all of them during baseline PES. After quinidine administration(466.7+-158.1mg/day), PES was performed again.The stimulation protocol included 2 basic cycle length (400ms,600ms) and up to 3 premature stimuli using two stimulation sites (right ventricular apex and right ventricular outflow tract). (Results)After oral administration of quinidine,VF was not induced in 5 of 9 patients. In 3 of the remaining 4 patients whom VF was still induced, more number of premature stimuli were needed than during baseline. 2 patients who received ICD implantation had multiple episodes of VF. Quinidine was effective in suppressing VF inducibility during PES for the one but not for the other. Clinically, both patients were asymptomatic during the follow-up periods of 20 months under quinidine treatment. (Conclusion) Quinidine has a possibility to prevent VF in Brugada syndrome.
机译:(背景)已知BMGADA综合征具有突然心脏死亡的高发病率。有效的治疗是ICD,并没有药物治疗。 (目的)探讨在口服奎尼丁后毒性综合征的症状或无症状患者中预防心室纤维刺激(PES)的疾病的影响。 (方法)PE在9名患者(所有男性,平均年龄53.9 + -13.0岁)中进行,他在基线PES期间展示了Characterstic Brugada型ECG.VF在它们中诱导。奎尼宁施用(466.7 + -158.1mg /天),再次进行PE。刺激方案包括2个基本循环长度(400ms,600ms),使用两个刺激位点(右心室顶点和右心室流出道最多3次过早刺激)。 (结果)口服奎尼丁施用后,VF未诱导9例患者中的5例。在剩余的4名患者中仍然诱导3例,需要更多的早熟刺激,而不是基线期间。 2名接受ICD植入的患者有多次VF发作。奎尼丁有效地抑制了PES的VF诱导性,但不是另一个。临床上,两种患者在奎尼丁治疗下在20个月的后续期间是无症状的。 (结论)奎尼丁有可能预防巴鲁达综合征的VF。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号